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Abstract
Introduction. Sepsis-induced acute lung injury (ALI) is an inflammatory process involved with simultaneous 
production of inflammatory cytokines and chemokines. In this study, we investigated the regulatory role of 
miR-539-5p in sepsis-induced ALI using a mouse model of cecal ligation puncture (CLP) and an in vitro model 
of primary murine pulmonary microvascular endothelial cells (MPVECs).
Material and methods. Adult male C57BL/6 mice were intravenously injected with or without miR-539-5p agomir 
or scrambled control one week before CLP operation. MPVECs were transfected with miR-539-5p mimics or 
control mimics, followed by lipopolysaccharide (LPS) stimulation. ROCK1 was predicted and confirmed as a direct 
target of miR-539-5p using dual-luciferase reporter assay. In rescue experiment, MPVECs were co-transfected 
with lentiviral vector expressing ROCK1 (or empty vector) and miR-539-5p mimics 24 h before LPS treatment. 
The transcriptional activity of caspase-3, the apoptosis ratio, the levels of miR-539-5p, interleukin-1b (IL-1b), 
interleukin-6 (IL-6), and ROCK1 were assessed. 
Results. Compared to sham group, mice following CLP showed pulmonary morphological abnormalities, elevat-
ed production of IL-1b and IL-6, and increased caspase-3 activity and apoptosis ratio in the lung. In MPVECs, 
LPS stimulation resulted in a significant induction of inflammatory cytokine levels and apoptosis compared to 
untreated cells. The overexpression of miR-539-5p in septic mice alleviated sepsis-induced pulmonary injury, 
apoptosis, and inflammation. MiR-539-5p also demonstrated anti-apoptotic and anti-inflammatory effect in 
LPS-treated MPVECs. The upregulation of ROCK1 in MPVECs recovered miR-539-5p-suppressed caspase-3 
activity and proinflammatory cytokine production. 
Conclusion. In conclusion, miR-539-5p alleviated sepsis-induced ALI via suppressing its downstream target 
ROCK1, suggesting a therapeutic potential of miR-539-5p for the management of sepsis-induced ALI. (Folia 
Histochemica et Cytobiologica 2019, Vol. 57, No. 4, 168–178)
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Introduction
Sepsis is life-threatening syndrome characterized by 
an excessive systemic inflammatory response to infec-
tions induced by pathogenic bacteria, fungi, or viruses 
[1]. Patients with severe sepsis commonly present 
with microvascular thrombosis and subsequent mul-
tiple organ dysfunction [2]. Acute lung injury (ALI) 
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is a clinical syndrome consisting of a wide range of 
acute hypoxemic respiratory failure disorders and has 
become one of the most common complications of 
severe sepsis [3]. Pathophysiological studies revealed 
that the injury to the alveolar epithelium and pulmo-
nary endothelial cells leads to an induction of epithelial 
permeability, pulmonary edema, and acute respiratory 
failure during the development of ALI [4]. However, 
no current available pharmacologic therapy has been 
recommended as a standard management of ALI [5]. 
Sepsis-induced ALI is an acute inflammatory process 
involved with simultaneous production of inflammato-
ry cytokines and chemokines. Interleukin-1b (IL-1b), 
for example, has been found in bronchoalveolar 
lavage fluids from ALI patients [6]. In patients 
with persistent acute respiratory distress syndrome, 
a more severe form of ALI, the high ratio of IL-1b 
to its antagonist suggested an essential role of IL-1b 
in maintaining chronic inflammatory condition in 
lungs [7]. The other key step in ALI progression is the 
extensive apoptosis of alveolar epithelial cells, which 
has been considered as a primary cause of lung epi-
thelium death in ALI patients [8]. Studies in murine 
endotoxin-induced lung injury models showed that the 
accumulation of soluble Fas ligand in Fas-dependent 
pathway induced apoptosis in lung epithelial cells [9, 
10]. Thus, the blockage of inflammatory response and 
apoptotic signaling in the lung might be a useful ther-
apeutic strategy in ameliorating sepsis-induced ALI. 
MicroRNAs (miRNAs) are a class of small 
non-coding RNAs that have shown an emerging reg-
ulatory role in many pathological processes, including 
sepsis-induced organ dysfunction [11]. The overex-
pression of miR-146a attenuated sepsis-triggered 
myocardial dysfunction in vitro via inhibiting NF-kB 
activation and the expression of inflammatory cy-
tokines [12]. MiR-27a mediated the protective effect 
of paclitaxel in the damaged liver from septic mice 
by suppressing NF-kB/TAB3 signaling pathway [13]. 
MiR-539-5p has been shown as a potent regulator in 
choroidal neovascularization and the migration of 
mesenchymal stem cells in fracture healing [14, 15]. 
However, whether it may exert beneficial effect in 
ALI remains unclear. 
In this study, we aimed to investigate the regu-
latory role and potential molecular mechanism of 
miR-539-5p in sepsis-induced ALI by using a murine 
sepsis model and the primary murine pulmonary 
microvascular endothelial cells. The degree of lung 
tissue injury, the level of apoptosis and the expression 
of inflammatory cytokines were examined. Our find-
ings may suggest a novel therapeutic approach in the 
management of septic ALI. 
Materials and methods
Mouse model of sepsis. A total of 24 adult male C57BL/6 
mice (28–32 g) were purchased from Charles River Labo-
ratories China and maintained in a controlled environment 
(12 h alternating light-dark cycle, 22–24°C, 60% humidity) 
with ad libitum access to food and water. All experiments in 
this study were approved by the Animal Care and Use Com-
mittee of The Central Hospital of Wuhan, and performed 
following the Guide for the Care and Use of Laboratory 
Animals [16]. After one-week acclimatization, 18 mice 
underwent cecal ligation and puncture (CLP) surgery to 
establish the model of CLP-induced sepsis as previously 
described [17, 18]. In brief, mice were anesthetized by i.p. in-
jection of 10% chloral hydrate (3 mL/kg, Sigma-Aldrich, St. 
Louis, MI, USA) and fixed on the operating table in supine 
position. A 4-mm longitudinal midline incision was made to 
expose the cecum. The exposed cecum was ligated at 10 mm 
from the tip using 3–0 silk sutures and then punctured once 
with a 20-gauge needle at 5 mm distal from the ligation. 
After extruding a small amount of feces by gently squeezing 
the cecum, the bowel was repositioned and the abdomi-
nal musculature, peritoneum and skin were closed using 
sterile sutures. Immediately after the surgery, 5 mL/100 g 
saline was subcutaneously injected for fluid resuscitation. 
Sham-operated mice (n = 6) underwent the same surgical 
procedure without the ligation or puncture of the cecum. 
In vivo delivery of plasmid DNA. CLP mice were randomly 
divided into three groups: CLP, CLP + NC agomir, and 
CLP + miR-539-5p agomir. The miRNA reagents, miR-
539-5p agomir and scrambled control (NC agomir), were 
purchased from GenePharm (Shanghai, China) and mixed 
with linear polyethyleneimine (PEI) nanoparticles (Sig-
ma-Aldrich) as previously described [19]. A total of 200 µL 
mixture containing 5 nmol miRNA (miR-539-5p agomir 
or NC agomir) was intravenously injected via the tail vein 
into designated group one week before the CLP operation. 
Animals were euthanized with carbon dioxide asphyxia 24 h 
post-surgery. Lungs were harvested and stored properly for 
further analyses.
Histological analysis. The same portion of the lung samples 
in mice were used for histopathological examination. Tissues 
were fixed in 4% paraformaldehyde, embedded in paraffin, 
cut into 5 μm sections, and then stained with hematoxylin 
and eosin (H&E). The degree of lung damage was estimated 
using lung injury scoring by an investigator blinded to the 
experiment as previously described [20]. Five randomly 
selected fields were scored per slide at magnification 400×. 
Cell culture and transfection. Primary murine pulmonary 
microvascular endothelial cells (MPVECs) were isolated 
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and cultured in DMEM (Sigma-Aldrich) as previously de-
scribed [21]. The miR-539-5p mimics and control mimics 
(50 nM) were synthesized by GenePharm and transfected 
into MPVECs using Lipofectamine 2000 (Invitrogen, Carls-
bad, CA, USA). Twenty-four hours after transfection, cells 
were stimulated with 1 mg/mL lipopolysaccharide (LPS, 
Sigma-Aldrich). The transcriptional activity of caspase-3 
was examined 30 min thereafter. The levels of miR-539-5p, 
interleukin-1b (IL-1b), interleukin-6 (IL-6), and ROCK1 
were assessed 6 h following the LPS treatment. In rescue 
experiment, MPVECs were co-transfected with 1 µg re-
combinant lentiviral vector expressing ROCK1 (or empty 
lentiviral vector) and 50 nM miR-539-5p mimics 24 h prior 
to the treatment with LPS. MPVECs co-transfected with 
empty lentiviral vector and control mimics were used as 
a control group. 
Dual-luciferase reporter assay. ROCK1 3’-UTR fragment 
containing the putative binding site of miR-539-5p was 
amplified and cloned into the downstream of luciferase 
gene in the pmirGlo vector (GenePharm). The mutant 
ROCK1 3’-UTR was used to construct ROCK1-MUT vec-
tor. HEK-293 cells were plated into 12-well plates (Thermo 
Fisher Scientific, Waltham, MA, USA) and co-transfected 
with miR-539-5p mimics (or NC mimics) and ROCK1-WT 
(or ROCK1-MUT) at 70–80% confluency. The luciferase 
activities were assessed 2 days after the transfection using 
Dual-Luciferase Reporter Assay System (Promega Biotech 
Co., Madison, WI, USA).
Quantitative real-time PCR (qRT-PCR). Target miRNA 
was extracted from mice lung tissues and MPVECs using 
mirVanaTM miRNA Isolation Kit (Invitrogen). The reverse 
transcription of miR-539-5p was performed using All-in-
OneTM miRNA RT-qPCR Detection Kit (GeneCopoeia 
Inc., Rockville, MD, USA). Total RNAs were isolated using 
Trizol LS (Invitrogen) and reverse transcribed to cDNA 
using the ReverTra Ace qPCR RT Kit (Toyobo, Osaka, 
Japan) according to the manufacturer’s instructions. Target 
genes were amplified using 7300 Real-Time PCR System 
(Applied Biosystem, Foster City, CA, USA). The expression 
of miR-539-5p was normalized by U6, while b-actin was 
used as internal control for mRNA expression. The primers 
used in this study were: miR-539-5p: GGAGAAAUUAUC-
CUUGGUGUGU; U6 forward: CTCGCTTCGGCAG-
CACA, U6 reverse: AACGCTTCACGAATTTGCGT; 
IL-1b forward: CCAGGATGAGGACCCAAGCA, IL-1b 
reverse: TCCCGACCATTGCTGTTTCC; IL-6 forward: 
TAGCCGCCCCACACAGACAG, IL-6 reverse: GGCT-
GGCATTTGTGGTTGGG; ROCK1 forward: AAA-
GAAAGGATGGAG-GATGAAGT, ROCK1 reverse: 
TGTAACAACAGCCGCTTATTTG; b-actin forward: AT-
CACTGCCACCCAGAAGAC, b-actin reverse: TTTCTA-
GACGGCAGGTCAGG. 
Enzyme-linked immunosorbent assay (ELISA). Total pro-
teins extracted from mice lung tissues and MPVEC lysates 
were prepared. Concentrations of IL-1b and IL-6 were 
measured using ELISA kits (R&D Systems, Minneapolis, 
MN, USA) according to the manufacturer’s protocol. 
Transcriptional activity assay. The transcriptional activity 
of caspase-3 in mice lung tissues and MPVECs were evalu-
ated using Caspase-3 Assay Kit (Abcam, Cambridge, UK) 
according to the manufacturer’s protocol. Lung samples 
were homogenized in RIPA buffer with protease inhibitor 
(Bio-Rad Laboratories, Hercules, CA, USA). MPVECs 
were lysed in cell lysis buffer 30 min after LPS stimulation. 
The protein concentration in all samples were adjusted to 
100–150 μg protein per 50 μL cell lysis buffer. The mixture 
of 50 μL 2 × Reaction Buffer and 10 mM DTT were added 
to 50 μL sample, followed by the incubation with 5 μL 4 mM 
DEVD-p-NA substrate at 37°C for 2 h. The optical density 
values for the peroxidase reaction product were measured 
at 450 nm using a microplate reader. 
Apoptosis assay. Cell apoptosis was assessed using Annexin 
V-FITC Apoptosis Detection Kit (#14085, Abcam,) accord-
ing to the manufacturer’s instructions. Briefly, MPVECs 
were cultured in 6-well plates to reach 70–80% confluency 
followed by the transfection and LPS stimulation as men-
tioned above. After 24 h, cells were collected, centrifuged, 
and resuspended in 500 µL 1 × buffer solution at the con-
centration of 5 × 105 cells/mL. Then 5 μL Annexin V-FITC 
and 5 μL propidium iodide (PI) were added to the cells 
and incubated at room temperature for 5 min in the dark. 
The apoptosis ratio was quantified in the flow cytometry 
analysis using BD FACS software (BD Biosciences, San 
Jose, CA, USA). 
Western blot. Total proteins (40–80 μg) from MPVEC 
lysates were separated on an 8% SDS-PAGE gel under 
reducing conditions and then transferred to polyvinylidene 
fluoride membranes (MilliporeSigma, Burlington, MA, 
USA). After blocking, membranes were incubated with 
ROCK1 antibody (1:2000, #ab45171, Abcam) and 
b-catenin antibody (1:2000, #ab32572, Abcam) at 4°C 
for 6 h. After three washes with TBST buffer, membranes 
were incubated with goat anti-rabbit secondary antibody 
(1:3000, #ab6721, Abcam) for 45 min. Protein bands were 
visualized using AlphalmagerTM 2000 Imaging System 
(Alpha Innotech, San Leandro, CA, USA) and the density 
of bands was quantified.
Statistical analysis. Data in this study are presented as 
mean ± standard deviation. The statistical significance 
was analyzed using two-tailed Student’s t-test or one-way 
ANOVA (SPSS software, version 24.0, Chicago, IL, USA). 
A value of p < 0.05 was considered statistically significant. 
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All experiments were performed in triplicate and repeated 
three times.
Results
MiR-539-5p was downregulated in mice with  
CLP-induced sepsis and the overexpression  
of miR-539-5p alleviated CLP-induced lung injury
To study the regulatory role of miR-539-5p in sep-
sis-induced ALI, we established a mouse model of 
sepsis induced by CLP surgery. The induction of 
miR-539-5p expression in septic mice was achieved by 
intravenous injection of miR-539-5p agomir prior to 
CLP treatment. Compared to sham-operated group, 
the expression of miR-539-5p in the lung tissues was 
significantly inhibited following CLP surgery. The 
injection of miR-539-5p-expressing plasmid in septic 
mice significantly promoted the level of miR-539-
5p compared to the ones administered with control 
miRNA (Fig. 1A). The degree of lung tissue damage 
was evaluated using lung injury scoring, in which 
miR-539-5p overexpression significantly improved 
the histological damage caused by CLP operation 
(Fig. 1B). As shown in the lung sections stained with 
H&E, sham-operated group showed morphologically 
normal structure of pulmonary alveoli. CLP mice, 
on the contrary, showed thickened alveolar walls 
and septa, collapsed alveolar sacs, visible vascular 
congestion and hemorrhage. The histopathological 
features in septic mice injected with control agomir 
were similar to those in CLP group. The induction of 
miR-539-5p alleviated the pulmonary alveoli damage 
induced by sepsis (Fig. 1C). These results suggested 
that miR-539-5p protected mice from sepsis-induced 
lung injury following CLP surgery. 
Induction of miR-539-5p decreased apoptosis  
marker activity and proinflammatory cytokine  
production in the lung tissues of CLP mice
We found that the transcriptional activity of caspase-3 
was significantly elevated in CLP-operated animals, 
whereas miR-539-5p overexpression induced a sig-
nificant reduction of caspase-3 activity in septic mice 
(Fig. 2A). The expressions of IL-1b and IL-6, two 
major proinflammatory cytokines, were significantly 
increased in septic animals at both mRNA and pro-
tein levels compared to sham-operated group. The 
induction of miR-539-5p in mice with ALI signifi-
cantly suppressed the expressions of both cytokines 
(Fig. 2B–C). These results indicated that miR-539-5p 
ameliorated sepsis-induced apoptosis and proinflam-
matory cytokine production. 
Overexpression of miR-539-5p reduced LPS-induced 
apoptosis and inflammation in MPVECs 
In this study, we stimulated MPVECs with LPS to 
mimic pulmonary damage in vitro. LPS-treated cells 
demonstrated significantly lower level of miR-539-5p 
compared to untreated cells. Under the condition of 
LPS stimulation, wild-type MPVECs and the ones 
transfected with control mimics showed similar miR-
539-5p level, whereas the delivery of miR-539-5p 
mimics significantly increased the expression of 
miR-539-5p (Fig. 3A). The caspase-3 activity was 
remarkably promoted by LPS treatment, while miR-
539-5p overexpression resulted in a significant reduc-
tion of caspase-3 activity in LPS-treated MPVECs 
(Fig. 3B). LPS-induced secretion of IL-1b and IL-6 
in MPVECs was also significantly impeded by miR-
539-5p (Fig. 3C–D). Flow cytometry data showed 
that LPS stimulated apoptosis in MPVECs, whereas 
the transfection of miR-539-5p mimics efficiently 
decreased the apoptosis ratio as compared to control 
mimics-transfected cells (Fig. 3E). The above findings 
suggested the anti-apoptotic and anti-inflammatory 
role of miR-539-5p in vitro. 
ROCK1 was directly targeted by miR-539-5p 
To explore the potential mechanisms underlying the 
involvement of miR-539-5p in ALI, we searched for 
the downstream target of miR-539-5p using bioinfor-
matics analysis on TargetScan. ROCK1 was predicted 
as a direct target gene of miR-539-5p with a putative 
binding site (Fig. 4A). Dual-luciferase reporter assay 
showed that the luciferase activity of ROCK1-WT was 
significantly lower in cells transfected with miR-539-5p 
mimics compared to control mimics cells. In contrast, 
cells transfected with ROCK1-MUT reporter showed 
no difference on the luciferase activity between miR-
539-5p mimics and control mimics groups (Fig. 4B). 
Then, we measured the mRNA and protein levels of 
ROCK1 in wild-type and miR-539-5p-overexpressing 
MPVECs and found that the expression of ROCK1 
was significantly downregulated by the induction of 
miR-539-5p (Fig. 4C).
MiR-539-5p inhibited apoptosis and inflammatory 
responses via the suppression of ROCK1
To further investigate whether miR-539-5p regulated 
apoptosis and inflammation via targeting ROCK1, we 
co-transfected MPVECs with miR-539-5p mimics and 
lentiviral vector expressing ROCK1 (or empty vector). 
The transfection efficacy was confirmed by significant-
ly augmented expressions of ROCK1 at both mRNA 
and protein levels in MPVECs transfected with 
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ROCK1 vector (Fig. 5A–B). We further explored the 
effect of ROCK1 overexpression on apoptosis and in-
flammation in MPVECs carrying miR-539-5p mimics. 
Compared to control cells, MPVECs co-transfected 
with miR-539-5p and empty vector showed signifi-
cantly impaired caspase-3 activity. The induction of 
Figure 1. Pulmonary expression of miR-539-5p in the mouse model of CLP-induced sepsis and the effect of miR-539-5p 
overexpression on sepsis-induced lung injury. Adult male C57BL/6 mice were divided into four groups: CLP, CLP + NC 
agomir, CLP + miR-539-5p, and sham group (n = 6 in each group). Animals in CLP, CLP + NC agomir, CLP + miR-539-5p 
groups were intravenously injected with vehicle, scrambled miRNA control, and miR-539-5p agomir, respectively, followed by 
CLP surgery. Sham group underwent the same surgical procedure of CLP without the ligation or puncture of the cecum. All 
animals were euthanized 24 h after the surgery, and their lung tissues were collected. A. Pulmonary expression of miR-539-5p 
was examined using qRT-PCR. B. Sectioned lung tissue samples were stained with H&E and the degree of lung damage was 
determined using lung injury scoring. C. Representative histological images were shown (400 × magnification). **p < 0.01.
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ROCK1, however, increased the activity of caspase-3 
back to the level that was shown in control group 
(Fig. 5C). The production of proinflammatory cytokines 
in MPVECs was largely inhibited by miR-539-5p 
overexpression, whereas ROCK1 led to a signifi-
cant upregulation of IL-1b and IL-6 at both mRNA 
and protein levels (Fig. 5D–E). Moreover, the over-
expression of miR-539-5p significantly decreased the 
apoptosis ratio of MPVECs, whereas the transfection 
of ROCK1-expressing vectors substantially facilitated 
MPVECs apoptosis (Fig. 5F). Taken together, these 
data indicated that miR-539-5p inhibited apoptosis 
Figure 2. Effect of miR-539-5p overexpression on apoptosis and inflammation in mice lungs following CLP-induced sepsis. 
A. The transcriptional activity of caspase-3 in lung tissues was measured using Caspase-3 Assay Kit. B–C. The pulmonary 
mRNA and protein levels of IL-1b and IL-6 were examined using qRT-PCR and ELISA, respectively. **p < 0.01.
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and inflammation in sepsis-induced ALI via the sup-
pression of its target gene ROCK1.
Discussion
Sepsis is a leading etiology of ALI that leads to more 
severe illness and higher mortality rates compared to 
non-sepsis risk factors [22]. As a syndrome developed 
from excessive inflammation, ALI affords multiple 
potential therapeutic targets and signaling pathways 
[23]. In the present study, we reported for the first 
time that miR-539-5p mitigated the development 
of sepsis-induced ALI both in vivo and in vitro. The 
induction of miR-539-5p in septic models decreased 
the expression of proinflammatory cytokines, IL-1b 
and IL-6, and suppressed the transcriptional activity 
of apoptosis marker, caspase-3. Further investigation 
revealed that miR-539-5p reduced apoptosis and 
inflammation in sepsis-induced ALI via the negative 
regulation of its downstream target ROCK1.
Mouse CLP model closely resembles the patho-
physiology of human sepsis caused by abdominal 
perforations and has been extensively used in the 
research of sepsis-induced organ dysfunction [24]. In 
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Figure 3. Induction of miR-539-5p affects the expression of apoptosis marker and proinflammatory cytokines in LPS-stim-
ulated primary murine pulmonary microvascular endothelial cells (MPVECs). Isolated MPVECs were divided into four 
groups: LPS (lipopolysaccharide), LPS + NC mimics, LPS + miR-539-5p mimics and Ctrl. Cells in LPS + NC mimics and 
LPS + miR-539-5p mimics groups were transfected with control mimics and miR-539-5p mimics, respectively, followed 
by the stimulation with 1 mg/mL. Cells in LPS group were stimulated with LPS without transfection. Control (Ctrl) cells 
remained untreated. A. Relative expression of miR-539-5p was assessed using qRT-PCR 6 h after the stimulation with 
lipopolysaccharides (LPS). B. The transcriptional activity of caspase-3 was examined 30 min following the treatment. C–D. 
The mRNA and protein levels of IL-1b and IL-6 were examined using qRT-PCR and ELISA, respectively. E. The apoptosis 
ratio in transfected MPVECs was calculated using flow cytometry analysis. **p < 0.01.
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this study, we successfully established the mouse mod-
el of sepsis-induced ALI by performing CLP surgery 
and showed morphological abnormalities in the lung, 
including thickened alveolar walls, collapsed alveolar 
sacs, vascular congestion and hemorrhage in CLP 
mice as compared to sham-operated group. Enhanced 
cell apoptosis and the induction of proinflammatory 
mediators during sepsis play crucial roles in the patho-
genesis of ALI [25]. IL-1b and IL-6 are two proinflam-
matory cytokines actively secreted in response to the 
inflammatory cascade in ALI [26, 27]. The inhibition 
of apoptotic signaling and inflammatory responses 
might potentially ameliorate sepsis-induced lung dam-
age. The caspase-3 activity is an important marker of 
cellular apoptosis. Increased activation of caspase-3 
has been reported in the animal models of ALI [28, 
29]. In the current study, enhanced caspase-3 activity, 
elevated production of IL-1b and IL-6, together with 
the increased apoptosis ratio was observed following 
CLP operation. LPS is an endotoxin constituting the 
outer membrane of Gram-negative bacteria, and 
has been widely used to induce acute lung injury in 
research [30]. In the in vitro model, incubation with 
LPS led to a significant induction of inflammatory 
cytokine levels and apoptosis in MPVECs compared 
to untreated cells. 
The potential involvement of miRNAs in ALI was 
first shown in a mouse model of LPS-induced lung 
injury, in which certain types of miRNAs were signifi-
cantly downregulated and the others were remarkably 
upregulated or remained unaltered [31]. Further in-
vestigations on the role of miRNAs in ALI suggested 
that miRNAs might regulate the inflammatory and 
apoptotic pathways during ALI progression by target-
ing specific molecules or regulating downstream genes 
[32]. Tuerdi et al. reported that the downregulation of 
miR-155 inhibited lung apoptosis and inflammation, 
and increased the survival rate in CLP-induced ALI 
mice by targeting SIRT1 [33]. The depletion of miR-
1246 reduced apoptosis, the release of IL-1b, and 
neutrophil infiltration in mice with ALI through the 
repression of its downstream target ACE2 [34]. Xie 
et al. showed significantly reduced expression of miR-
127 during lung injury in vivo, while the administration 
of miR-127 probes attenuated pulmonary inflamma-
tion through the regulation of CD46 in macrophages 
[35]. In another animal study, the upregulation of 
miR146a suppressed the secretion of TNF-a, IL-6, 
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Figure 4. ROCK1 is a direct target of miR-539-5p. ROCK1 was predicted as a direct downstream target of miR-539-5p 
using TargetScan. A. The putative ROCK1 binding site for miR-539-5p (ROCK1-WT) and the designed mutant sequence 
(ROCK1-MUT) were shown. B. HEK-293T cells were co-transfected with NC mimics (or miR-539-5p mimics) and ROCK1-
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Figure 5. MiR-539-5p mediated apoptosis and inflammation via regulating ROCK1. MPVECs were divided into three 
groups: miR-539-5p + Vector, miR-539-5p + ROCK1 and Vector + NC mimics. In miR-539-5p + Vector and miR-539-
5p + ROCK1 groups, MPVECs were co-transfected with miR-539-5p mimics and lentiviral vector expressing ROCK1 (or 
empty lentiviral vector) 24 h before LPS stimulation. MPVECs in Vector + NC mimics group were co-transfected with 
empty lentiviral vector and control mimics. A–B. To evaluate the transfection efficacy, the mRNA and protein levels of 
ROCK1 in miR-539-5p + Vector and miR-539-5p + ROCK1 groups were analyzed using qRT-PCR and Western blot. C. 
The transcriptional activity of caspase-3 was examined 30 min post-stimulation. D–E. The mRNA and protein levels of IL-1b 
and IL-6 were determined using qRT-PCR and ELISA, respectively. F. The apoptosis ratio in transfected MPVECs was 
calculated using flow cytometry analysis. **p < 0.01.
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and IL-1b in LPS-induced ALI model via the inhibi-
tion of IRAK-1 and TRAF-6 [36]. In our study, we 
showed that the level of miR-539-5p was significantly 
downregulated in CLP-operated mice compared to 
the sham group. The delivery of miR-539-5p mimics 
prior to CLP surgery efficiently alleviated sepsis-in-
duced pulmonary injury, reduced caspase-3 activity 
and apoptosis, suppressed the induction of inflam-
matory cytokines IL-1b and IL-6. The anti-apoptotic 
and anti-inflammatory effect of miR-539-5p were also 
shown in LPS-treated MPVECs. 
ROCK1 has been predicted and confirmed as 
a direct downstream target of miR-539-5p in our study. 
A previous study in CLP rat model showed that the 
activation of ROCK1 was involved in the pathogenesis 
of sepsis-induced ALI with a potential mechanism 
related to oxidative stress and apoptosis [37]. Here, by 
enhancing the expression of ROCK1 in MPVECs, the 
beneficial effect of miR-539-5p in ALI-associated ap-
optosis and inflammation was significantly reversed. It 
indicated that miR-539-5p ameliorated sepsis-induced 
ALI by repressing its downstream target ROCK1.
In conclusion, miR-539-5p alleviated sepsis-in-
duced apoptosis and proinflammatory cytokine pro-
duction during ALI by downregulating the expression 
of ROCK1. This study highlighted the potential of 
miR-539-5p as a therapeutic target for the manage-
ment of sepsis-induced ALI. 
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